Search

everythinglearnresearchcommunity

for

Search:↓

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Topical treatments led to hair regrowth in a man with linear morphea.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Estrogen increases a growth factor in hair cells which might affect hair loss.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Mechanical stretching of the skin can promote hair growth by activating certain immune cells.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Type-2 immunity may influence skin diseases and could be targeted for treatment.